Ledger.Open graph →
SEC Form D · Amendment · filed July 22, 2021

Tallac Therapeutics, Inc

Offering
$61.6M
Sold
$61.6M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
BURLINGAME, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Jaume Pons · Burlingame, CADirectorMichael Carusi · Burlingame, CADirectorChristine Brennan · Burlingame, CADirectorIsaac Cheng · Burlingame, CADirectorHong Wan · Burlingame, CAExec · DirectorCorey Goodman · Burlingame, CADirectorAndrew Menlove · SALT LAKE CITY, UTDirectorTally Ringwood · SALT LAKE CITY, UTDirectorConnor Mclaughlin · NEW YORK, NYDirectorGreg Moritz · Marietta, GADirectorWeston Reynolds · New York, NYDirectorShreyans Jain · Frisco, TXExec · DirectorRan Geng · Burlingame, CADirectorJosh Sharkey · Cortlandt Manor, NYDirectorJonathan Davila · Tampa, FLExec · DirectorMark Swanson · Tampa, FLDirectorMatthew Leyrer · Dallas, TXDirectorScott Mcmullin · Los Angeles, CADirectorChristopher Rising · Los Angeles, CADirectorRan Geng · Burlingame, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗